CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia

BackgroundAcute Myeloid leukemia is a heterogeneous disease that requires novel targeted treatment options tailored to the patients’ specific microenvironment and blast phenotype.MethodsWe characterized bone marrow and/or blood samples of 37 AML patients and healthy donors by high dimensional flow c...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Laurène Pousse, Koorosh Korfi, Bruno C. Medeiros, Marco Berrera, Nadine Kumpesa, Jan Eckmann, Idil Karakoc Hutter, Vera Griesser, Vaios Karanikas, Christian Klein, Maria Amann
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2023-05-01
coleção:	Frontiers in Oncology
Assuntos:	acute myeloid leukemia (AML) leukemic stem cells (LSC) regulatory T cell (Treg) CD25 antibody dependent cellular cytotoxicity (ADCC)
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1150149/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!